Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imperial Innovations Businesses
United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Imperial Innovations manages a diversified portfolio of 98 companies across healthcare, engineering/materials, and ICT sectors. Notable portfolio companies include Cell Medica (cellular immunotherapy with Phase II trials underway), PsiOxus (oncolytic vaccine platform with Orphan Drug Designation), Veryan Medical (helical stent technology with CE mark approval), and Autifony (hearing loss and tinnitus therapeutics in Phase II).
- Therapeutic areas
- HematologyCardiovascularNeurologyInfectious DiseasesOncology
- Modalities
- Cell therapyMonoclonal antibodyOncolytic virus therapySmall moleculeGene therapyAntibody-drug conjugateDevice
- Industry
- Investors
02
Partnerships
Woodford Investment ManagementInvesco Perpetual/Invesco Asset Management (42.0% shareholding)European Investment Bank (EIB loan)Biosensors International (distribution agreement with Veryan)Max-Delbrück-Centre of Molecular Medicine (manufacturing partner for Cell Medica)Apollo Therapeutics (co-founded with Imperial College, Cambridge, UCL)
Beyond the preview
Go deeper on Imperial Innovations Businesses.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imperial Innovations Businesses.